Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Postoperative Ileus
Interventions: caffeinated coffee; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Photosensitive Epilepsy
Interventions: BRV vs LEV in randomized double blinded, crossover fashion; Drug
Lead sponsor: Rosenfeld, William E., M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Prostate Cancer, PSA, Infection
Interventions: Systematic Transrectal biopsy (TR-Bx), Targeted Transrectal biopsy (TR-Bx), Systematic Transperineal biopsy (TP-Bx), Targeted Transperineal biopsy (TP-Bx); Procedure
Lead sponsor: Albany Medical College; Other
Eligibility: Male only
Enrollment: 840 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Albany, New York

Conditions: Infection, Human Immunodeficiency Virus
Interventions: Reyataz + Norvir + Truvada, Reyataz + Epzicom; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 44
States / cities: Hobson City, Alabama • Phoenix, Arizona • Bakersfield, California + 36 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: MedImmune LLC; Industry
Eligibility: 40 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Baltimore, Maryland • Springfield, Massachusetts • St Louis, Missouri + 6 more

Conditions: Aortic Stenosis Treated With TAVI, Aortic Diseases
Interventions: F2 Filter and Delivery System, Transcatheter Aortic Valve Replacement (TAVR); Device · Procedure
Lead sponsor: EnCompass Technologies, Inc.; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Naples, Florida • Indianappolis, Indiana • Detroit, Michigan + 5 more

Conditions: Heart Transplant
Interventions: L-arginine; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 8 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Wounds and Injuries, Venous Thromboembolism
Interventions: Aspirin and Rosuvastatin, Placebo (for Aspirin and Rosuvastatin); Drug
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Cervicogenic Headache
Interventions: Musculoskeletal Physical Therapy; Procedure
Lead sponsor: Faith Regional Health Services; Other
Eligibility: 19 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Norfolk, Nebraska

Conditions: Mucopolysaccharidosis II
Interventions: Observational; Other
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: 1 Month to 8 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Oakland, California • Philadelphia, Pennsylvania

Conditions: Periampullary Neoplasms, Pancreatic Cancer, Pancreatic Neoplasms
Interventions: Total Pancreatectomy with Islet Autotransplantation (TPIAT); Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Isolated Clubfoot
Interventions: Foot Abduction Brace (FAB); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Up to 1 Year
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 7
States / cities: Sacramento, California • Orlando, Florida • Lexington, Kentucky + 3 more

Conditions: Brain Tumors, Non-CNS Malignancies
Interventions: Quality of Life surveys completed at specified timepoints; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 2 Years to 25 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: Insulet Artificial Pancreas (AP) System; Device
Lead sponsor: Insulet Corporation; Industry
Eligibility: 6 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 4
States / cities: Palo Alto, California • Santa Barbara, California • Walnut Creek, California + 1 more

Conditions: Hernia, Pain, Postoperative, Abdominal Wall Relaxation After Rectus Sheath Block
Interventions: Bupivacaine, Normal Saline; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: GERD, Gastroesophageal Reflux Disease
Interventions: LINX device; Device
Lead sponsor: Torax Medical Incorporated; Industry
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 12
States / cities: Tucson, Arizona • Rogers, Arkansas • Los Angeles, California + 9 more

Conditions: Scoliosis Idiopathic
Interventions: Enhanced Recovery After Surgery Protocol; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cytomegalovirus Infections, HIV Infections
Interventions: Valganciclovir; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 56
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 33 more

Conditions: Cancer Risk, Breast Cancer Risk
Interventions: Magnetic resonance imaging (MRI), Artificial Intelligence (AI); Procedure · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 89 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: San Diego, California • San Francisco, California • Chicago, Illinois + 1 more

Conditions: Duodenal Neoplasm, Pancreatic Neoplasm
Interventions: Bupivacaine, Hydromorphone, Iopamidol, Liposomal Bupivacaine, Medical Chart Review, Questionnaire Administration, Thoracic Epidural Analgesia, Ultrasound Imaging, X-Ray Imaging; Drug · Other · Procedure
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Low Back Pain, Lumbosacral Radiculopathy, Lumbar Disc Degeneration, Lumbar Disc Herniation, Stenosis, Spondylolisthesis, Spondylolysis, Deformity of Spine
Interventions: Exparel, Bupivacaine; Drug
Lead sponsor: Virtua Health, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Mount Holly, New Jersey

Conditions: Lower Urinary Tract Injury
Interventions: cystoscopy; Device
Lead sponsor: AdventHealth; Other
Eligibility: Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Winter Park and Celebration, Florida

Conditions: Human Microbiome
Interventions: Pomella, Placebo; Dietary Supplement · Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 25 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Pulmonary Lesions, Pulmonary Nodules, Pulmonary Mass
Interventions: Standard FB with fluoroscopy, R-EBUS with ultrathin bronchoscope; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 22 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Gainesville, Florida • Baltimore, Maryland + 2 more

Search by objective public record fields.

Does Coffee Consumption Prevent or Shorten Postoperative Ileus After Colon Resection?

Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint

Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Prospective L-arginine Study

STAT-STatin and Aspirin in Trauma

McKenzie Method of Mechanical Diagnosis and Therapy for Management of Cervicogenic Headache: A Prospective Case Series

Mucopolysaccharidosis Type II Observational

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial

Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies

Insulet Artificial Pancreas Early Feasibility Study

Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions

LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy

Complex Spine Enhanced Recovery After Surgery (ERAS)

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief

"Laparoscopic" Cystoscopy Versus Traditional Cystoscopy

Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )